NCT07013474

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-07-14Est. Completion: 2027-09-27

Enrollment target: 300 participants

Locations

Hope Clinical Research, Inc., Canoga Park, California, United States
Amicis Research Center - Granada Hills, Granada Hills, California, United States
Jacobs Medical Center at UC San Diego Health, La Jolla, California, United States
UC Davis CTSC Clinical Research Center, Sacramento, California, United States
University of California Davis Health, Sacramento, California, United States
UC San Diego Medical Center - Hillcrest, San Diego, California, United States
University of California San Diego Health, San Diego, California, United States
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus, Aurora, Colorado, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
University of Colorado Clinical and Translational Research Center, Aurora, Colorado, United States
University of Colorado Hospital, Aurora, Colorado, United States
Georgetown University Medical Center, Washington D.C., District of Columbia, United States
BRP- Hialeah Hospital, Hialeah, Florida, United States
D&H Cancer Research Center LLC, Margate, Florida, United States

Cardiac Amyloidosis

Cardiac amyloidosis is a condition where the heart muscle, amongst other tissues, is infiltrated by the abnormal build-u…

London, United KingdomEst. completion Dec 2027

Lung Transplant

This is a trial in which 350 primary lung transplant recipients will be randomized (1:1) to receive either Tocilizumab (…

Phoenix, United StatesEst. completion Jan 8, 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.